244 related articles for article (PubMed ID: 7912675)
1. Rat interleukin-2-activated natural killer (A-NK) cell-mediated lysis is determined by the presence of CD18 on A-NK cells and the absence of major histocompatibility complex class I on target cells.
Smits KM; Kuppen PJ; Eggermont AM; Tamatani T; Miyasaka M; Fleuren GJ
Eur J Immunol; 1994 Jan; 24(1):171-5. PubMed ID: 7912675
[TBL] [Abstract][Full Text] [Related]
2. Multiple natural killer cell-activating signals are inhibited by major histocompatibility complex class I expression in target cells.
Correa I; Corral L; Raulet DH
Eur J Immunol; 1994 Jun; 24(6):1323-31. PubMed ID: 8206092
[TBL] [Abstract][Full Text] [Related]
3. Self class I molecules protect normal cells from lysis mediated by autologous natural killer cells.
Ciccone E; Pende D; Vitale M; Nanni L; Di Donato C; Bottino C; Morelli L; Viale O; Amoroso A; Moretta A
Eur J Immunol; 1994 Apr; 24(4):1003-6. PubMed ID: 8149950
[TBL] [Abstract][Full Text] [Related]
4. Adhesion molecule-mediated signals regulate major histocompatibility complex-unrestricted and CD3/T cell receptor-triggered cytotoxicity.
Galandrini R; Albi N; Zarcone D; Grossi CE; Velardi A
Eur J Immunol; 1992 Aug; 22(8):2047-53. PubMed ID: 1379184
[TBL] [Abstract][Full Text] [Related]
5. The regulatory role of CD45 on rat NK cells in target cell lysis.
Giezeman-Smits KM; Gorter A; van Vlierberghe RL; v Eendenburg JD; Eggermont AM; Fleuren GJ; Kuppen PJ
J Immunol; 1999 Jul; 163(1):71-6. PubMed ID: 10384101
[TBL] [Abstract][Full Text] [Related]
6. p40, a novel surface molecule involved in the regulation of the non-major histocompatibility complex-restricted cytolytic activity in humans.
Poggi A; Pella N; Morelli L; Spada F; Revello V; Sivori S; Augugliaro R; Moretta L; Moretta A
Eur J Immunol; 1995 Feb; 25(2):369-76. PubMed ID: 7875198
[TBL] [Abstract][Full Text] [Related]
7. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
[TBL] [Abstract][Full Text] [Related]
8. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
[TBL] [Abstract][Full Text] [Related]
9. Preincubation of tumor cells with the anti-(MHC) class I antibody OX18 enhances tumor cell lysis by interleukin-2-activated NK cells.
Smits KM; Kuppen PJ; Eggermont AM; Fleuren GJ
Transplant Proc; 1993 Oct; 25(5):2806-7. PubMed ID: 8212242
[No Abstract] [Full Text] [Related]
10. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and gamma/delta TCR+ T lymphocytes. II. Modulation of natural killer cytotoxicity by anti-Kp43 monoclonal antibody.
Aramburu J; Balboa MA; Izquierdo M; López-Botet M
J Immunol; 1991 Jul; 147(2):714-21. PubMed ID: 1830071
[TBL] [Abstract][Full Text] [Related]
11. Relation of natural killer cell line NK-92-mediated cytolysis (NK-92-lysis) with the surface markers of major histocompatibility complex class I antigens, adhesion molecules, and Fas of target cells.
Komatsu F; Kajiwara M
Oncol Res; 1998; 10(10):483-9. PubMed ID: 10338151
[TBL] [Abstract][Full Text] [Related]
12. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells.
Karlhofer FM; Ribaudo RK; Yokoyama WM
Nature; 1992 Jul; 358(6381):66-70. PubMed ID: 1614533
[TBL] [Abstract][Full Text] [Related]
13. Protection against natural killer cells by interferon-gamma treatment of K562 cells cannot be explained by augmented major histocompatibility complex class I expression.
Nishimura M; Mitsunaga S; Akaza T; Mitomi Y; Tadokoro K; Juji T
Immunology; 1994 Sep; 83(1):75-80. PubMed ID: 7821970
[TBL] [Abstract][Full Text] [Related]
14. CD54/ICAM-1 is a costimulator of NK cell-mediated cytotoxicity.
Chong AS; Boussy IA; Jiang XL; Lamas M; Graf LH
Cell Immunol; 1994 Aug; 157(1):92-105. PubMed ID: 7518755
[TBL] [Abstract][Full Text] [Related]
15. Negative regulation of rat natural killer cell activity by major histocompatibility complex class I recognition.
Kraus E; Lambracht D; Wonigeit K; Hünig T
Eur J Immunol; 1996 Nov; 26(11):2582-6. PubMed ID: 8921942
[TBL] [Abstract][Full Text] [Related]
16. MHC class I expression on tumor targets inhibits natural killer cell-mediated cytotoxicity without interfering with target recognition.
Kaufman DS; Schoon RA; Leibson PJ
J Immunol; 1993 Feb; 150(4):1429-36. PubMed ID: 8432986
[TBL] [Abstract][Full Text] [Related]
17. Use of anti-HLA antibodies to mask major histocompatibility complex gene products on tumor cells can enhance susceptibility of these cells to lysis by natural killer cells.
Lobo PI; Spencer CE
J Clin Invest; 1989 Jan; 83(1):278-87. PubMed ID: 2463268
[TBL] [Abstract][Full Text] [Related]
18. Dual effects of cytokines in regulation of MHC-unrestricted cell mediated cytotoxicity.
Reiter Z
Crit Rev Immunol; 1993; 13(1):1-34. PubMed ID: 8466640
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of murine natural killer (NK) cells by a monoclonal antibody specific for the NK1.1 antigen. IL-2-activated NK cells possess additional specific stimulation pathways.
Karlhofer FM; Yokoyama WM
J Immunol; 1991 May; 146(10):3662-73. PubMed ID: 2026886
[TBL] [Abstract][Full Text] [Related]
20. Alloreactive natural killer cells in the rat: complex genetics of major histocompatibility complex control.
Naper C; Vaage JT; Lambracht D; Løvik G; Butcher GW; Wonigeit K; Rolstad B
Eur J Immunol; 1995 May; 25(5):1249-56. PubMed ID: 7774627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
